Drug Markets/Dupilumab

Dupilumab

4 NDCs across 1 manufacturer|0 Generic,4 Brand

Dupilumab is used to treat atopic dermatitis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

In 2024, Medicare Part D spent $2.5 billion on Dupilumab across 621,000 claims for 88,000 beneficiaries.

Dupilumab is available as 4 NDCs from 1 manufacturer (0 generic, 4 brand), with NADAC prices from $1009.56 to $1778.86 per ML — a 76% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

4

0G / 4B

Manufacturers

1

competing in market

Price Spread

$1009.56 – $1778.86

per ML

7d Activity

3↑1↓0 flat

avg +0.0% WoW · of 4 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing DUPILUMAB

Drug Portfolio

4 NDCs total, 4 shown

Drug ↕Price 7d Change ↕
DUPIXENT 200 MG/1.14 ML PEN
$1778.8589
per ML
+0.03%
DUPIXENT 200 MG/1.14 ML SYRING
$1773.7351
per ML
+0.03%
DUPIXENT 300 MG/2 ML SYRINGE
$1010.5955
per ML
-0.08%
DUPIXENT 300 MG/2 ML PEN
$1009.5592
per ML
+0.04%

Frequently Asked Questions

What is Dupilumab used to treat?

Dupilumab is used to treat atopic dermatitis, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Dupilumab?

In 2024, Medicare Part D spent $2.5 billion on Dupilumab across 621,000 claims for 88,000 beneficiaries.

How many Dupilumab products are on the market?

The Dupilumab drug market contains 4 NDCs from 1 manufacturer — 0 generic and 4 brand products.

What is the price range for Dupilumab?

NADAC reference prices for Dupilumab range from $1009.5592 to $1778.8589 per ML — a 76% difference between cheapest and most expensive.

Which manufacturers make Dupilumab?

1 manufacturer lists Dupilumab in NADAC. Ranked by number of NDCs, the largest are Sanofi-Aventis U.S. LLC (4).

How has the price of Dupilumab changed recently?

Over the past 7 days, 3 Dupilumab NDCs rose and 1 fell, with a market-wide average change of +0.0%.